Health Care • Medical/Nursing Services
$8.51 ▼ -0.22
(-2.52%)
MKT CAP: $1.55B • VOL: 8.16M
52W L $4 52W H $10
TDOC // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $2.53B | $2.57B | $2.60B |
| YoY Revenue Growth % | -1.5% | -1.3% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$263.0M | -$1.02B | -$248.6M |
| Operating Margin % | -10.4% | -39.7% | -9.6% |
| Net Income (GAAP) | -$200.3M | -$1.00B | -$220.4M |
| EBITDA (Normalized) | -$255.8M | -$1.01B | -$154.9M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $294.4M | $293.7M | $350.0M |
| Capital Expenditures (CapEx) | $8.9M | $10.8M | $117.1M |
| Free Cash Flow (FCF) | $285.5M | $282.9M | $232.9M |
| FCF Margin % | 11.3% | 11.0% | 8.9% |
| Return on Invested Capital (ROIC %) | -16.4% | -45.0% | -10.4% |
| Cash & Short-Term Equivalents | $781.1M | $1.30B | — |
| Total Debt (Short + Long Term) | $662.7M | $911.5M | $730.8M |
| Total Stockholders' Equity | $1.39B | $1.49B | $1.50B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR TDOC.